News & Articles
Selected Filters:
Vaccines still effective against Delta variant of concern, says Oxford-led study of the COVID-19 Infections Survey
Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant
Long COVID uncommon in children, analysis finds
Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks
Digital obsolescence: Is your research data at risk?
Experts discuss how technological advances result in a ‘graveyard of software’ and describe a compliant solution designed to safeguard vital data for generations to come
Dotmatics to deliver the foundation for Croda’s R&D digital program: artificial intelligence and data mining
Project supports Croda’s global Research & Development Digital Program across all R&D locations
Researchers develop a promising new therapy to tackle metabolic liver disease, NASH
Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis
Longer interval between Pfizer vaccine doses boosts immunity
Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells
High blood sugar levels ‘reprogramme’ stem cells
Findings explain higher risk of heart attack in people with diabetes, even after treatment
A year of clinical research change, challenge, and champions: Your questions answered
Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment
Quantifying cellular microenvironments with spatial analysis
Watch this on-demand to learn how to leverage your spatial analysis with CytoMAP
Roche’s Actemra/RoActemra receives FDA EUA for the treatment of COVID-19
The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients
Mixed Oxford/Pfizer vaccine schedule provides 'robust' COVID-19 protection
Mixed schedules involving Pfizer-BioNTech and Oxford-AstraZeneca generate strong immune response against SARS-CoV2 spike IgG protein
Highlights from the Virtual Clinical Science Summit 2021
Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand
5 top trending videos on cell preparation, incubation and storage
Watch exclusive interviews with leading industry experts on the importance of precision cold storage equipment
Automated science to create the Lab of the Future
Watch this on-demand webinar to discover digital solutions, lab automation, and technological advancements that are paving the way for laboratory productivity and innovation
The Orchestrated Lab webinar series: Explore the latest in LIMS, artificial intelligence, cloud capabilities, and much more
Join us on Tuesday, 20 April, to learn how technology-driven strategies can promote success and how automated science is a key driving factor
bioMérieux launches EPISEQ SARS-COV-2, a cloud-based software application for the epidemiological surveillance of SARS-CoV-2 variants
EPISEQ SARS-COV-2 will support microbiology labs in identification and reporting from raw sequencing data related to SARS-CoV-2 variants
Meet the winners of the 2021 Scientists’ Choice Awards for Clinical Science
Scientific, technological and communications excellence has been celebrated at the Clinical Science Summit, with Beckman Coulter, Zymo Research, and PerkinElmer among those recognized
One year’s experience of large-scale SARS-CoV-2 testing in Luxembourg: Your questions answered
Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg
Luminex submits joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA
The multi-analyte respiratory panel combines Flu A/B and respiratory syncytial virus (RSV) targets with the SARS-CoV-2 target
























